Beryl Drugs Ltd Q4 FY2023-2024 Results: Summary
Revenue | ₹3.21Cr |
Net Profits | ₹0.35Cr |
Net Profit Margins | -10.90% |
Highlights
Revenue:
Beryl Drugs Ltd’s revenue fell -47.29% since last year same period to ₹3.21Cr in the Q4 2023-2024. On a quarterly growth basis, Beryl Drugs Ltd has generated -58.09% fall in its revenue since last 3-months.
Net Profits:
Beryl Drugs Ltd’s net profit fell -683.33% since last year same period to ₹0.35Cr in the Q4 2023-2024. On a quarterly growth basis, Beryl Drugs Ltd has generated -212.9% fall in its net profits since last 3-months.
Net Profit Margins:
Beryl Drugs Ltd’s net profit margin fell -1206.7% since last year same period to -10.90% in the Q4 2023-2024. On a quarterly growth basis, Beryl Drugs Ltd has generated -369.42% fall in its net profit margins since last 3-months.
